Klassen Preston

CIK 0001493056

President & Head of R & DDirector

Filings

Latest Jun 27, 2025

Issuers covered

Showing

14 of 14

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Klassen Preston. Track record appears once open-market purchases or sales reach the +30 day horizon.

Companies where Klassen Preston has filed

Ticker	Issuer	Filings	Last filed
RGLS	Regulus Therapeutics Inc.	9	Jun 27, 2025
MTCR	Metacrine, Inc.	5	Mar 24, 2023

14 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Jun 27, 2025	RGLSRegulus Therapeutics Inc.	DDisposition	115,555	-	-
Jun 4, 2025	RGLSRegulus Therapeutics Inc.	PPurchase	12,000	$7.9877	$95,852
Jan 31, 2025	RGLSRegulus Therapeutics Inc.	Holdings only	-	-	-
Jan 15, 2025	RGLSRegulus Therapeutics Inc.	SSale	31,445	$1.2632	$39,721
Jan 10, 2025	RGLSRegulus Therapeutics Inc.	AGrant	37,500	$1.36	$51,000
May 21, 2024	RGLSRegulus Therapeutics Inc.	Holdings only	-	-	-
Jan 17, 2024	RGLSRegulus Therapeutics Inc.	Holdings only	-	-	-
Aug 14, 2023	RGLSRegulus Therapeutics Inc.	Holdings only	-	-	-
Jun 12, 2023	RGLSRegulus Therapeutics Inc.	Holdings only	-	-	-
Mar 24, 2023	MTCRMetacrine, Inc.	AGrant	842,211	$0.47	$395,839
Jan 27, 2023	MTCRMetacrine, Inc.	SSale	380,605	$0.4132	$157,266
Apr 20, 2022	MTCRMetacrine, Inc.	SSale	43,575	$0.5021	$21,879
Apr 18, 2022	MTCRMetacrine, Inc.	AGrant	104,500	$0.00	$0
Mar 1, 2022	MTCRMetacrine, Inc.	AGrant	842,211	$0.00	$0

Showing 1-14 of 14

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.